Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.34
+0.8%
$1.41
$1.13
$3.88
$56.60M0.18485,945 shs406,004 shs
Check-Cap Ltd stock logo
MBAI
Check-Cap
$1.79
-10.5%
$1.68
$0.59
$3.92
$13.05M0.571.74 million shs247,246 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$1.14
-2.6%
$1.46
$1.02
$2.93
$53.40M0.82182,255 shs189,666 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.61
+4.6%
$4.05
$2.82
$5.92
$59.43M1.1984,882 shs97,016 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pulmonx Corporation stock logo
LUNG
Pulmonx
+3.10%+3.10%-7.64%-6.34%-59.94%
Check-Cap Ltd stock logo
MBAI
Check-Cap
+18.34%+39.86%+11.11%+9.89%+199,999,900.00%
InspireMD, Inc. stock logo
NSPR
InspireMD
-2.50%+0.86%-13.33%-31.18%-51.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+2.37%-15.65%-22.12%-25.81%-24.84%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pulmonx Corporation stock logo
LUNG
Pulmonx
$1.34
+0.8%
$1.41
$1.13
$3.88
$56.60M0.18485,945 shs406,004 shs
Check-Cap Ltd stock logo
MBAI
Check-Cap
$1.79
-10.5%
$1.68
$0.59
$3.92
$13.05M0.571.74 million shs247,246 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$1.14
-2.6%
$1.46
$1.02
$2.93
$53.40M0.82182,255 shs189,666 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.61
+4.6%
$4.05
$2.82
$5.92
$59.43M1.1984,882 shs97,016 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pulmonx Corporation stock logo
LUNG
Pulmonx
+3.10%+3.10%-7.64%-6.34%-59.94%
Check-Cap Ltd stock logo
MBAI
Check-Cap
+18.34%+39.86%+11.11%+9.89%+199,999,900.00%
InspireMD, Inc. stock logo
NSPR
InspireMD
-2.50%+0.86%-13.33%-31.18%-51.85%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+2.37%-15.65%-22.12%-25.81%-24.84%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pulmonx Corporation stock logo
LUNG
Pulmonx
2.38
Hold$5.38301.39% Upside
Check-Cap Ltd stock logo
MBAI
Check-Cap
1.00
SellN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50294.74% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.57
Moderate Buy$6.8890.44% Upside

Current Analyst Ratings Breakdown

Latest MBAI, SRTS, LUNG, and NSPR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingBuy
5/5/2026
InspireMD, Inc. stock logo
NSPR
InspireMD
Reiterated RatingOverweight$4.00 ➝ $3.00
5/4/2026
InspireMD, Inc. stock logo
NSPR
InspireMD
Set Price Target$4.00
4/30/2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
Reiterated RatingBuy$14.00
4/24/2026
Check-Cap Ltd stock logo
MBAI
Check-Cap
Reiterated RatingSell (D-)
4/21/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Reiterated RatingSell (D)
3/6/2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Initiated CoverageBuy$7.50
3/5/2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
Lower Price TargetBuy$6.00 ➝ $5.00
3/5/2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
Reiterated RatingBuy$14.00
2/24/2026
InspireMD, Inc. stock logo
NSPR
InspireMD
Set Price Target$5.00
2/24/2026
InspireMD, Inc. stock logo
NSPR
InspireMD
Reiterated RatingBuy
(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pulmonx Corporation stock logo
LUNG
Pulmonx
$88.55M0.64N/AN/A$1.08 per share1.24
Check-Cap Ltd stock logo
MBAI
Check-Cap
N/AN/A$0.60 per share2.98$0.47 per shareN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.85M4.92N/AN/A$1.83 per share0.62
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$22.53M2.64N/AN/A$2.93 per share1.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$54M-$1.30N/AN/AN/A-60.09%-92.94%-39.80%7/29/2026 (Estimated)
Check-Cap Ltd stock logo
MBAI
Check-Cap
$4.14M-$2.77N/AN/AN/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$7.72M-$0.47N/AN/AN/A-34.50%-15.41%-13.70%N/A

Latest MBAI, SRTS, LUNG, and NSPR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-$0.1250-$0.16-$0.0350-$0.16$5.32 million$3.39 million
4/29/2026Q1 2026
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.33-$0.33N/A-$0.33$20.43 million$20.59 million
3/4/2026Q4 2025
Pulmonx Corporation stock logo
LUNG
Pulmonx
-$0.39-$0.2518+$0.1382-$0.25$21.73 million$22.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Pulmonx Corporation stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Check-Cap Ltd stock logo
MBAI
Check-Cap
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pulmonx Corporation stock logo
LUNG
Pulmonx
0.81
4.91
4.04
Check-Cap Ltd stock logo
MBAI
Check-Cap
N/A
0.05
0.05
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
9.72
6.31

Institutional Ownership

CompanyInstitutional Ownership
Pulmonx Corporation stock logo
LUNG
Pulmonx
91.04%
Check-Cap Ltd stock logo
MBAI
Check-Cap
1.07%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Pulmonx Corporation stock logo
LUNG
Pulmonx
6.80%
Check-Cap Ltd stock logo
MBAI
Check-Cap
0.48%
InspireMD, Inc. stock logo
NSPR
InspireMD
29.72%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
10.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pulmonx Corporation stock logo
LUNG
Pulmonx
25042.24 million39.37 millionOptionable
Check-Cap Ltd stock logo
MBAI
Check-Cap
807.29 million7.25 millionN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
5046.84 million18.33 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.46 million14.78 millionOptionable

Recent News About These Companies

Sensus Healthcare Q1 Earnings Call Highlights
Sensus (SRTS) Q1 2026 Earnings Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Pulmonx stock logo

Pulmonx NASDAQ:LUNG

$1.34 +0.01 (+0.75%)
Closing price 04:00 PM Eastern
Extended Trading
$1.34 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Check-Cap stock logo

Check-Cap NASDAQ:MBAI

$1.79 -0.21 (-10.50%)
Closing price 04:00 PM Eastern
Extended Trading
$1.68 -0.11 (-6.15%)
As of 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

InspireMD stock logo

InspireMD NYSE:NSPR

$1.14 -0.03 (-2.56%)
Closing price 04:00 PM Eastern
Extended Trading
$1.15 +0.01 (+0.53%)
As of 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.61 +0.16 (+4.64%)
Closing price 04:00 PM Eastern
Extended Trading
$3.64 +0.04 (+0.97%)
As of 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.